Navigation Links
New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer
Date:12/10/2008

The above mentioned studies and data represent the latest results of clinical research for each treatment and are not necessarily part of the indicated licence in each country. For detailed label information, visit the website of your health authority or the EMEA website http://www.emea.europa.eu/

Note to Editors

Breast cancer is the most common cancer among women worldwide.(i) Each year more than one million new cases of breast cancer are diagnosed worldwide, and nearly 400,000 people will die of the disease annually. (ii) In HER2- positive breast cancer, increased quantities of the HER2 protein are present on the surface of the tumour cells. This is known as 'HER2-positivity'. High levels of HER2 are present in a particularly aggressive form of the disease which responds poorly to chemotherapy. Research shows that HER2-positivity affects approximately 20-30 percent of women with breast cancer.(iii)

About Roche

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the

central nervous system. In 2007 sales by the Pharmaceuticals Division totaled 36.8 billion Swiss francs, and the Diagnostics Division posted sales of 9.3 billion francs. Roche has R&D agreements and strategic alliances with numerous
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
5. Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
6. Novel Xeloda(R) Dosing Schedule May Offer Well-Tolerated Alternative for Treatment of Advanced Breast Cancer
7. Nearly 60 New Studies of Oral Xeloda(R) (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting
8. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
9. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
10. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
11. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... 2014  BioSpecifics Technologies Corp. (NASDAQ: BSTC ), ... as XIAFLEX ® in the U.S. and XIAPEX ® ... Tom Wegman , will present at the following upcoming investor ... & Renshaw 16 th Annual Global Investment ... September 9, 2014 at 9:10 a.m. EDT , ...
(Date:9/2/2014)... SAN DIEGO , Sept. 2, 2014 /PRNewswire/ ... an oncology company focused on the clinical development ... it has completed enrollment in a randomized Phase ... candidate Pracinostat in combination with azacitidine in patients ... (MDS). The multi-center, placebo-controlled, double-blind study enrolled a ...
(Date:9/2/2014)... ANTONIO , Sept. 2, 2014 ... medical technology company focused on innovating lifesaving devices ... the appointment of Dr. Gabriele Niederauer , ... and CEO. Following the recent closure of Series ... Mark for the Surfacer™ Inside-Out Access Catheter System, ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences 2MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome 2MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome 3MEI Pharma Completes Enrollment In Randomized Phase II Clinical Trial Of Pracinostat In Front Line Myelodysplastic Syndrome 4Bluegrass Vascular Technologies Names Dr. Gabriele Niederauer President And CEO 2
... THOUSAND OAKS, Calif., Sept. 24 Amgen (Nasdaq: ... EPOGEN® and PROCRIT® (Epoetin alfa) vials are being voluntarily ... as a precaution.  The product that is being recalled ... barely visible in most cases. The lamellae result from ...
... Pharmasset, Inc. (Nasdaq: VRUS ) announces that management ... September 27-28, 2010 at the New York Palace Hotel, New ... will provide an overview of the company at the JMP ... To access a simultaneous webcast of Mr. Price,s ...
Cached Medicine Technology:Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 2Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 3Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 4Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 5Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 6Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 7Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 8Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 9Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 10Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 11Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 12Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 13Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 14Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 15Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 16Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 17Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 18Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 19Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 20Amgen Initiates Voluntary Nationwide Recall of Certain Lots of EPOGEN® and PROCRIT® (Epoetin alfa) 21Pharmasset to Present at the JMP Healthcare Conference 2Pharmasset to Present at the JMP Healthcare Conference 3
(Date:9/2/2014)... Two Kansas State University biochemists have discovered a ... for Staphylococcus aureus , a pathogenic bacterium that ... year. , Brian Geisbrecht, professor of biochemistry and molecular ... S. aureus , which is the cause of ... scientific journal Proceedings of the National Academy of ...
(Date:9/2/2014)... Vertebral invasive compression fractures called spine fractures, ... our spine suffers crack or gets deformed. Vertebral compression ... with osteoporosis or low bone density. Though osteoporosis is ... metastatic tumors and extensive trauma such as an accident, ... lead to such fractures. , The placement of such ...
(Date:9/2/2014)... 02, 2014 HMP Communications Holdings ... is proud to announce the acquisition of Nutrition411.com ... designed for healthcare professionals who integrate diet and nutrition ... access to:, , Late-breaking news related ... topic centers for diabetes, oncology, renal disease, wound care, ...
(Date:9/2/2014)... As an industry transformation expert, it was ... predict change. Fortunately for him, that valuable skill has stuck ... that are eager for change — such as the hearing ... market indicated it was ripe for better customer service, better ... a result, he took matters into his own hands and ...
(Date:9/2/2014)... New research involving mice suggests that the key to ... medicine cabinet. In a report published in the ... that macrophages from the lungs of old mice had ... from young mice, but these changes were reversed by ... consequences on immune function," said Joanne Turner, Ph.D., a ...
Breaking Medicine News(10 mins):Health News:Biochemists find new treatment options for staph infections, inflammatory diseases 2Health News:An Overview of the Minimally Invasive Vertebral Compression Fracture Repair Market by Transparency Market Research 2Health News:An Overview of the Minimally Invasive Vertebral Compression Fracture Repair Market by Transparency Market Research 3Health News:HMP Communications Holdings, LLC, Acquires Nutrition411.com 2Health News:David Sapio Launches Zounds Hearing Franchise 2
... Vitamin D, but be Careful Not to Burn Cautions Tanning ... Indoor Tanning Association (ITA) is encouraging beach goers to tan ... good health, overexposure to UV light can be a dangerous ... order for tanners to get all the benefits of UV ...
... 16 , WHO: Nancy Floyd Haworth Foundation (Breast cancer Education and, ... 18th annual Breast Cancer Luncheon and 3 FREE Educational Seminars, WHEN: Saturday, ... 9:00 AM--12 Noon: 3 FREE ... choose two you wish to attend. Call (505) 265-6343 to reserve your seat.) ...
... Nuclear Cardiology and Cardiac CT, is taking place in ... the ESC Working Group on Nuclear Cardiology and Cardiac ... and the American Society of Nuclear Cardiology (ASNC), now ... Nuclear Cardiology and Cardiac CT through practice, education and ...
... high-density genome wide analysis of participants in the Alzheimer,s ... complete and that data will be shared with scientists ... data will be used by researchers to search for ... which currently affects up to 5 million people in ...
... has workers looking over their shoulders according to ... of U.S. workers said their work atmosphere felt ... Tell It Now(SM) survey released by ComPsych today. ... "panicky." ComPsych Corporation is the world,s largest provider ...
... Physicians to E-Prescribing as First Step Toward Connected ... -- A new public/private partnership called PaperFree ... launched a plan to jump-start America,s electronic health ... 100 "electronic healthcare ambassadors" with a goal to ...
Cached Medicine News:Health News:Indoor Tanning Association Promotes Responsible Tanning for Spring Breakers 2Health News:Breast Cancer Awareness Event Including Free Educational Seminars 2Health News:Cardiac imaging highlighted at Biennial ICNC-9 2Health News:Cardiac imaging highlighted at Biennial ICNC-9 3Health News:Cardiac imaging highlighted at Biennial ICNC-9 4Health News:Alzheimer's Disease Neuroimaging Initiative announces completion of genome-wide analysis 2Health News:Alzheimer's Disease Neuroimaging Initiative announces completion of genome-wide analysis 3Health News:Work Atmosphere Is Worried, Panicky, Say Majority of U.S. Employees 2Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 2Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 3Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 4Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 5Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 6Health News:Tampa Bay Becomes First Community to Jump-Start America's E-Health Revolution 7
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: